世界の骨密度測定装置市場(~2027年):種類別(DEXA、末梢)、用途別(骨減少症&骨粗鬆症、嚢胞性線維症、CKD、体組成測定、関節リウマチ)、エンドユーザー別(病院&専門クリニック、診断センター)

【英語タイトル】Bone Densitometer Market by Type (DEXA, Peripheral), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Body Composition Measurement, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic Centres) - Global Forecast to 2027

MarketsandMarketsが出版した調査資料(MD7438-22)・商品コード:MD7438-22
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年7月14日
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

MarketsandMarkets社の最新調査レポートによると、世界の骨密度測定装置市場規模は、2022年299百万ドルから2027年378百万ドルまで年平均4.7%拡大すると見込まれています。当書では骨密度測定装置の世界市場を総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業動向、技術別(軸骨格骨密度測定、末梢骨骨密度測定)分析、種類別(DEXA、末梢)分析、用途別(骨減少症&骨粗鬆症診断、嚢胞性線維症診断、慢性腎臓病診断、体組成測定、関節リウマチ診断)分析、エンドユーザー別(病院&専門クリニック、診断&画像センター、その他)分析、地域別分析、競争状況、企業情報など、以下の項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業動向
・世界の骨密度測定装置市場規模:技術別(軸骨格骨密度測定、末梢骨骨密度測定)
・世界の骨密度測定装置市場規模:種類別(DEXA、末梢)
・世界の骨密度測定装置市場規模:用途別(骨減少症&骨粗鬆症診断、嚢胞性線維症診断、慢性腎臓病診断、体組成測定、関節リウマチ診断)
・世界の骨密度測定装置市場規模:エンドユーザー別(病院&専門クリニック、診断&画像センター、その他)
・世界の骨密度測定装置市場規模:地域別
・競争状況
・企業情報

“世界の骨密度測定装置市場は、2022年の2億9,900万米ドルから2027年3億7,800万米ドルまで、予測期間中にCAGR4.7%で成長すると予測”
骨密度測定装置は、骨中のカルシウムやその他のミネラルの量を測定するために使用されます。骨密度測定装置は主に骨減少症や骨粗鬆症の検出に使用されます。

“軸性骨密度測定セグメントが骨密度測定装置市場で最大シェアを占める見込み”
軸骨密度測定装置は臨床医の様々な要求を満たすものであり、これが市場成長を促進する大きな要因となっています。これらの機器は、診断手順で正確な結果を得るために不可欠な中心二重エネルギーX線吸収測定ベースのツールを主に含みます。

“骨粗鬆症・骨減少症診断セグメントが骨密度測定装置市場で最大シェアを占める見込み”
骨粗鬆症&骨減少症診断セグメントは、2021年に世界の骨密度測定装置市場で最大のシェアを占めました。骨粗鬆症に罹患する高齢者人口の多さ、更年期女性における骨粗鬆症リスクの増加が、このセグメントの成長を促進する主な要因です。

“病院&専門クリニックセグメントが骨密度測定装置市場で最大シェアを占める見込み”
2021年の世界の骨密度測定装置市場では、病院&専門クリニックセグメントが最大シェアを占めています。病院は高価な機器を購入する経済力があり、骨密度測定装置を効果的に使用できる訓練を受けた専門家がいます。また、専門クリニックでは、骨粗鬆症や骨減少症などの様々な病状の診断や体格測定のために骨密度測定装置を使用しています。

“アジア太平洋市場が予測期間中に最も高い成長率を記録”
APAC市場は予測期間中に最も高いCAGRで成長すると推定されます。アジア諸国(特に中国とインド)は、主に高齢者人口の増加、骨粗鬆症の罹患率の増加、医療費の増加、それぞれの医療制度における病院や診療所の数の増加により、予測期間中に市場プレーヤーに大きな成長機会を提供すると期待されています。

本レポートで参照した骨密度測定装置市場の主要参入企業の内訳は以下の通りです:
- 企業タイプ別 ティア1-33%、ティア2-45%、ティア3-22%
- 役職別 Cレベル-31%、ディレクターレベル-37%、その他-22%
- 地域別 北米-35%、欧州-30%、アジア太平洋-15%、中南米-10%、中東・アフリカ-10%

骨密度測定装置の主要企業は、GE Healthcare (US)、Hologic, Inc. (US)、OSI Systems, Inc. (US)、Diagnostic Medical Systems Group (France)、Swissray Global Healthcare Holding, Ltd. (Taiwan)、BeamMed, Ltd. (Israel)、Echolight S.P.A (Italy)、Scanflex Healthcare AB (Sweden)、Medonica Co., Ltd. (South Korea)、Eurotec Systems S.r.l (Italy)、AMPall Co., Ltd. (South Korea)、L’acn L’accessorio Nucleare S.R.L (Italy)、Shenzhen XRAY Electric Co., Ltd. (China)、YOZMA BMTech Co., Ltd. (South Korea)、Nanoomtech Co., Ltd. (South Korea)、Osteosys Corporation (South Korea)、古野電気株式会社(日本)、Xianyang Kanrota Digital Ultrasound System, Co., Ltd. (China)、XinGaoYi Co., Ltd. (China)、Anjue Medical Equipment (China)、Guangzhou Medsinglong Medical Equipment Co., Ltd. (China)、Trivitron Healthcare (India)、OsCare Medical Oy (Finland)、CyberLogic, Inc. (US)、Nanjing Kejin Industrial Co., Ltd. (China)などです。

調査範囲
様々な骨密度測定装置の市場とその採用パターンを分析しています。世界の骨密度測定装置市場の市場規模や今後の成長性、技術、用途、エンドユーザー、地域などの異なるセグメントを推定することを目的としています。また、この市場の主要企業の会社概要、製品・サービス内容、最近の動向とともに、詳細な競合分析も掲載しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業にとっても、市場の動向を把握する上で有益であり、ひいては、より大きなシェアを獲得する上で役立ちます。本レポートを購入された企業は、市場での存在感を高めるために、以下の5つの戦略のいずれか、または任意の組み合わせを使用することができます。

本レポートでは、以下のポイントに関する洞察を提供しています:
- 市場への浸透: 骨密度測定装置の世界市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報
- 製品開発/イノベーション: 骨密度測定装置の世界市場における今後の動向、研究開発活動、製品・サービスの発売に関する詳細な洞察
- 市場開発: 種類別、用途別、エンドユーザー別、地域別の有利な新興地域に関する包括的情報
- 市場の多様化: 骨密度測定装置の世界市場における新製品、成長地域、最新動向に関する詳細情報
- 競合評価: 世界の骨密度測定装置市場における主要企業の市場シェア、成長戦略、収益分析、製品・サービスに関する詳細な評価。

❖ レポートの目次 ❖

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.2.1 MARKETS COVERED 25
1.2.2 YEARS CONSIDERED 25
1.3 CURRENCY 26
1.4 LIMITATIONS 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 1 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 28
FIGURE 2 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Breakdown of primary sources 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 30
FIGURE 4 BOTTOM-UP APPROACH 30
FIGURE 5 TOP-DOWN APPROACH 31
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2021) 31
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32
FIGURE 7 DATA TRIANGULATION METHODOLOGY 32
2.4 MARKET SHARE ESTIMATION 33
2.5 ASSUMPTIONS 33
3 EXECUTIVE SUMMARY 34
FIGURE 8 BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION) 34
FIGURE 9 BONE DENSITOMETERS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 35
FIGURE 10 BONE DENSITOMETERS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 35
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE BONE DENSITOMETERS MARKET 36

4 PREMIUM INSIGHTS 37
4.1 BONE DENSITOMETERS MARKET OVERVIEW 37
FIGURE 12 INCREASING PREVALENCE OF OSTEOPOROSIS TO DRIVE
THE MARKET FOR BONE DENSITOMETERS 37
4.2 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION AND
COUNTRY (2021) 38
FIGURE 13 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS SEGMENT DOMINATED
THE ASIA PACIFIC BONE DENSITOMETERS MARKET IN 2021 38
4.3 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39
FIGURE 14 CHINA TO WITNESS THE HIGHEST GROWTH IN THE BONE DENSITOMETERS MARKET FROM 2022 TO 2027 39
4.4 REGIONAL MIX: BONE DENSITOMETERS MARKET (2022–2027) 40
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2022–2027) 40
4.5 BONE DENSITOMETERS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 40
FIGURE 16 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
FIGURE 17 BONE DENSITOMETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.2 MARKET DRIVERS 42
5.2.1 RISING INCIDENCE OF OSTEOPOROSIS 42
5.2.2 GROWING GERIATRIC POPULATION 42
5.2.3 RISING PREVALENCE OF KIDNEY DISEASE 42
5.3 MARKET RESTRAINTS 43
5.3.1 HIGH COST OF BONE DENSITOMETERS 43
5.4 MARKET OPPORTUNITIES 43
5.4.1 GROWTH OPPORTUNITIES IN EMERGING MARKETS 43
TABLE 1 EMERGING COUNTRIES: HEALTHCARE EXPENDITURE (% OF GDP),
2015 VS. 2019 43
5.5 MARKET CHALLENGES 44
5.5.1 LACK OF ACCESS TO DIAGNOSTICS 44
5.5.2 UNFAVORABLE REIMBURSEMENT SCENARIO 44
5.5.3 HOSPITAL BUDGET CUTS 44
5.6 ASSESSMENT OF COVID-19 IMPACT ON THE ECONOMIC SCENARIO OF THE BONE DENSITOMETERS MARKET 45
6 BONE DENSITOMETERS MARKET, BY TECHNOLOGY 46
6.1 INTRODUCTION 47
TABLE 2 BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 47

6.2 AXIAL BONE DENSITOMETRY 47
TABLE 3 AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 47
TABLE 4 AXIAL BONE DENSITOMETRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 48
6.2.1 DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA) 48
6.2.1.1 Several advantages of DEXA scanners to drive growth
in this market segment 48
TABLE 5 DUAL-ENERGY X-RAY ABSORPTIOMETRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 49
6.2.2 QUANTITATIVE COMPUTED TOMOGRAPHY (QCT) 49
6.2.2.1 Several drawbacks of QCT scanners, including relatively high radiation exposure and a higher precision error than that of DEXA, to limit market growth 49
TABLE 6 QUANTITATIVE COMPUTED TOMOGRAPHY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 50
6.3 PERIPHERAL BONE DENSITOMETRY 50
TABLE 7 PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 51
TABLE 8 PERIPHERAL BONE DENSITOMETRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 51
6.3.1 QUANTITATIVE ULTRASOUND (QUS) 52
6.3.1.1 Quantitative ultrasound scanners offer advantages such as low exposure to radiation and non-invasive measurement—key factors driving market growth 52
TABLE 9 QUANTITATIVE ULTRASOUND MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 52
6.3.2 RADIOGRAPHIC ABSORPTIOMETRY (RA) 53
6.3.2.1 Technical limitations associated with RA devices to limit market growth 53
TABLE 10 RADIOGRAPHIC ABSORPTIOMETRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 53
6.3.3 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES 54
TABLE 11 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 54
7 BONE DENSITOMETERS MARKET, BY APPLICATION 55
7.1 INTRODUCTION 56
TABLE 12 BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 56
7.2 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS 56
7.2.1 LARGE GERIATRIC POPULATION SUFFERING FROM OSTEOPOROSIS
AND INCREASING RISK OF OSTEOPOROSIS IN MENOPAUSAL
WOMEN—KEY FACTORS DRIVING GROWTH 56
TABLE 13 BONE DENSITOMETERS MARKET FOR OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 57

7.3 CYSTIC FIBROSIS DIAGNOSIS 57
7.3.1 GROWING PREVALENCE OF CYSTIC FIBROSIS AND SUBSEQUENT INCREASE IN CASES OF OSTEOPOROSIS & OSTEOPENIA TO DRIVE THE DEMAND FOR BONE DENSITY TESTS 57
TABLE 14 BONE DENSITOMETERS MARKET FOR CYSTIC FIBROSIS DIAGNOSIS,
BY COUNTRY, 2020–2027 (USD MILLION) 58
7.4 CHRONIC KIDNEY DISEASE DIAGNOSIS 58
7.4.1 GROWING PREVALENCE OF CHRONIC KIDNEY DISEASES TO INCREASE THE DEMAND FOR BONE DENSITOMETRY TESTS 58
TABLE 15 BONE DENSITOMETERS MARKET FOR CHRONIC KIDNEY DISEASE DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 59
7.5 BODY COMPOSITION MEASUREMENT 59
7.5.1 GROWING FOCUS ON ATHLETE PERFORMANCE TO SUPPORT MARKET GROWTH 59
TABLE 16 BONE DENSITOMETERS MARKET FOR BODY COMPOSITION MEASUREMENT, BY COUNTRY, 2020–2027 (USD MILLION) 60
7.6 RHEUMATOID ARTHRITIS DIAGNOSIS 60
7.6.1 HIGH RISK OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES ASSOCIATED WITH RHEUMATOID ARTHRITIS TO FUEL THE NEED FOR BONE DENSITOMETERS 60
TABLE 17 BONE DENSITOMETERS MARKET FOR RHEUMATOID ARTHRITIS DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 61
8 BONE DENSITOMETERS MARKET, BY END USER 62
8.1 INTRODUCTION 63
TABLE 18 BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 63
8.2 HOSPITALS & SPECIALTY CLINICS 63
8.2.1 HIGH PURCHASING CAPACITY OF HOSPITALS COMPARED TO DIAGNOSTIC AND AMBULATORY CENTERS TO DRIVE THE ADOPTION OF HIGH-COST DEXA SCANNERS AMONG HOSPITALS 63
TABLE 19 BONE DENSITOMETERS MARKET FOR HOSPITALS & SPECIALTY CLINICS,
BY COUNTRY, 2020–2027 (USD MILLION) 64
8.3 DIAGNOSTIC & IMAGING CENTERS 64
8.3.1 HIGH COST OF BONE DENSITOMETERS AND CONTINUOUS REIMBURSEMENT CUTS IN OUTPATIENT DIAGNOSTIC IMAGING TO LIMIT GROWTH IN THIS END-USER SEGMENT 64
TABLE 20 BONE DENSITOMETERS MARKET FOR DIAGNOSTIC & IMAGING CENTERS,
BY COUNTRY, 2020–2027 (USD MILLION) 65
8.4 OTHER END USERS 65
TABLE 21 BONE DENSITOMETERS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 66

9 BONE DENSITOMETERS MARKET, BY REGION 67
9.1 INTRODUCTION 68
FIGURE 18 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
TABLE 22 BONE DENSITOMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 68
TABLE 23 BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
9.2 NORTH AMERICA 69
FIGURE 19 NORTH AMERICA: BONE DENSITOMETERS MARKET SNAPSHOT 70
TABLE 24 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 71
TABLE 25 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 71
TABLE 26 NORTH AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 71
TABLE 27 NORTH AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 72
TABLE 28 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 72
TABLE 29 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 72
9.2.1 US 73
9.2.1.1 Favorable reimbursement scenario in the US to drive market growth 73
TABLE 30 US: KEY MACROINDICATORS 73
TABLE 31 US: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 74
TABLE 32 US: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 74
TABLE 33 US: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 74
TABLE 34 US: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 75
TABLE 35 US: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 75
9.2.2 CANADA 75
9.2.2.1 Growing geriatric population in Canada to support market growth 75
TABLE 36 CANADA: KEY MACROINDICATORS 76
TABLE 37 CANADA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 76
TABLE 38 CANADA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 76
TABLE 39 CANADA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 77
TABLE 40 CANADA: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 77
TABLE 41 CANADA: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 77

9.3 EUROPE 78
TABLE 42 EUROPE: BONE DENSITOMETERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 78
TABLE 43 EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 78
TABLE 44 EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 79
TABLE 45 EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 79
TABLE 46 EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 79
TABLE 47 EUROPE: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 80
9.3.1 GERMANY 80
9.3.1.1 Growing prevalence of osteoporosis in Germany to fuel the demand for bone densitometers in the country 80
TABLE 48 GERMANY: KEY MACROINDICATORS 80
TABLE 49 GERMANY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 81
TABLE 50 GERMANY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 81
TABLE 51 GERMANY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 81
TABLE 52 GERMANY: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 82
TABLE 53 GERMANY: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 82
9.3.2 FRANCE 82
9.3.2.1 Increasing healthcare expenditure in France to boost the adoption of bone densitometers 82
TABLE 54 FRANCE: KEY MACROINDICATORS 83
TABLE 55 FRANCE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 83
TABLE 56 FRANCE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 83
TABLE 57 FRANCE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 84
TABLE 58 FRANCE: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 84
TABLE 59 FRANCE: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 84
9.3.3 UK 85
9.3.3.1 Increasing number of fragility fracture cases to drive growth in the UK bone densitometers market 85
TABLE 60 UK: KEY MACROINDICATORS 85
TABLE 61 UK: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 85
TABLE 62 UK: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 86
TABLE 63 UK: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 86
TABLE 64 UK: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 86
TABLE 65 UK: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 87
9.3.4 ITALY 87
9.3.4.1 Large geriatric population in the country and subsequent increase in the prevalence of age-related chronic conditions to fuel growth in the market 87
TABLE 66 ITALY: KEY MACROINDICATORS 87
TABLE 67 ITALY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 88
TABLE 68 ITALY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 88
TABLE 69 ITALY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 88
TABLE 70 ITALY: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 89
TABLE 71 ITALY: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 89
9.3.5 SPAIN 89
9.3.5.1 Improved monitoring of fragility fractures and their management through national registries to propel the market for bone densitometers in Spain 89
TABLE 72 SPAIN: KEY MACROINDICATORS 90
TABLE 73 SPAIN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 90
TABLE 74 SPAIN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 91
TABLE 75 SPAIN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 91
TABLE 76 SPAIN: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 91
TABLE 77 SPAIN: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 92
9.3.6 REST OF EUROPE 92
TABLE 78 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 92
TABLE 79 REST OF EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 92
TABLE 80 REST OF EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 81 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 93
TABLE 82 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 93
9.4 ASIA PACIFIC 94
FIGURE 20 ASIA PACIFIC: BONE DENSITOMETERS MARKET SNAPSHOT 94
TABLE 83 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 95
TABLE 84 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 95
TABLE 85 ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 95
TABLE 86 ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 96
TABLE 87 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 96
TABLE 88 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 96
9.4.1 JAPAN 97
9.4.1.1 Large geriatric population in Japan to fuel the demand for bone densitometers 97
TABLE 89 JAPAN: KEY MACROINDICATORS 97
TABLE 90 JAPAN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 98
TABLE 91 JAPAN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 98
TABLE 92 JAPAN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 98
TABLE 93 JAPAN: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 99
TABLE 94 JAPAN: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 99
9.4.2 CHINA 99
9.4.2.1 Increasing incidence of fractures due to osteoporosis to support market growth 99
TABLE 95 CHINA: KEY MACROINDICATORS 100
TABLE 96 CHINA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 100
TABLE 97 CHINA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 100
TABLE 98 CHINA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 101
TABLE 99 CHINA: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 101
TABLE 100 CHINA: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 101
9.4.3 INDIA 102
9.4.3.1 Rising osteoporosis & osteoarthritis rates to support the demand for bone densitometers in India 102
TABLE 101 INDIA: KEY MACROINDICATORS 102
TABLE 102 INDIA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 102
TABLE 103 INDIA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
TABLE 104 INDIA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 103
TABLE 105 INDIA: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 103
TABLE 106 INDIA: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 104
9.4.4 REST OF ASIA PACIFIC 104
TABLE 107 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 104
TABLE 108 REST OF ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET,
BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 109 REST OF ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET,
BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 110 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 111 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 105
9.5 LATIN AMERICA 106
9.5.1 EFFORTS TO CLOSE THE CARE GAP AND INCREASE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH IN LATIN AMERICA 106
TABLE 112 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 106
TABLE 113 LATIN AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 107
TABLE 114 LATIN AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 115 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 107
TABLE 116 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY END USER,
2020–2027 (USD MILLION) 108
9.6 MIDDLE EAST & AFRICA 108
9.6.1 POLITICAL INSTABILITY IN THE MIDDLE EAST & AFRICA TO HINDER MARKET GROWTH 108
TABLE 117 MIDDLE EAST & NORTH AFRICA: NUMBER OF HIP FRACTURES,
2010 VS. 2020 108
TABLE 118 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 109
TABLE 119 MIDDLE EAST & AFRICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 120 MIDDLE EAST & AFRICA: PERIPHERAL BONE DENSITOMETRY MARKET,
BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 121 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 122 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 110

10 COMPETITIVE LANDSCAPE 111
10.1 INTRODUCTION 111
10.2 COMPETITIVE LEADERSHIP MAPPING 111
10.2.1 STARS 111
10.2.2 EMERGING LEADERS 111
10.2.3 PERVASIVE PLAYERS 112
10.2.4 PARTICIPANTS 112
FIGURE 21 BONE DENSITOMETERS MARKET: COMPETITIVE LEADERSHIP
MAPPING, 2021 112
10.3 BONE DENSITOMETERS MARKET: GEOGRAPHICAL ASSESSMENT 113
FIGURE 22 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN
THE BONE DENSITOMETERS MARKET (2021) 113
10.4 MARKET SHARE ANALYSIS 114
FIGURE 23 BONE DENSITOMETERS MARKET SHARE, BY KEY PLAYER, 2021 114
10.5 COMPETITIVE SITUATION AND TRENDS 115
10.5.1 DEALS (2019–2022) 115
10.5.2 OTHER DEVELOPMENTS (2021) 115
11 COMPANY PROFILES 116
11.1 KEY PLAYERS 116
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 GE HEALTHCARE 116
TABLE 123 GE HEALTHCARE: BUSINESS OVERVIEW 116
FIGURE 24 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 117
11.1.2 HOLOGIC, INC. 119
TABLE 124 HOLOGIC, INC.: BUSINESS OVERVIEW 119
FIGURE 25 HOLOGIC, INC.: COMPANY SNAPSHOT (2021) 120
11.1.3 OSI SYSTEMS, INC. 122
TABLE 125 OSI SYSTEMS, INC.: BUSINESS OVERVIEW 122
FIGURE 26 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 123
11.1.4 DIAGNOSTIC MEDICAL SYSTEMS GROUP 125
TABLE 126 DIAGNOSTIC MEDICAL SYSTEMS GROUP: BUSINESS OVERVIEW 125
11.1.5 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD. 126
TABLE 127 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD.: BUSINESS OVERVIEW 126
11.1.6 BEAMMED, LTD. 127
TABLE 128 BEAMMED, LTD.: BUSINESS OVERVIEW 127
11.1.7 ECHOLIGHT S.P.A 128
TABLE 129 ECHOLIGHT S.P.A.: BUSINESS OVERVIEW 128
11.1.8 SCANFLEX HEALTHCARE AB 129
TABLE 130 SCANFLEX HEALTHCARE AB: BUSINESS OVERVIEW 129
11.1.9 MEDONICA CO., LTD. 130
TABLE 131 MEDONICA CO., LTD.: BUSINESS OVERVIEW 130
11.1.10 EUROTEC MEDICAL SYSTEMS S.R.L. 131
TABLE 132 EUROTEC MEDICAL SYSTEMS S.R.L.: BUSINESS OVERVIEW 131
11.2 OTHER PLAYERS 132
11.2.1 AMPALL CO., LTD. 132
TABLE 133 AMPALL CO., LTD.: BUSINESS OVERVIEW 132
11.2.2 L’ACN L’ACCESSORIO NUCLEARE S.R.L 133
TABLE 134 L’ACN L’ACCESSORIO NUCLEARE S.R.L.: BUSINESS OVERVIEW 133
11.2.3 SHENZHEN XRAY ELECTRIC CO., LTD. 134
TABLE 135 SHENZHEN XRAY ELECTRIC CO., LTD.: BUSINESS OVERVIEW 134
11.2.4 YOZMA BMTECH CO., LTD. 135
TABLE 136 YOZMA BMTECH CO., LTD.: BUSINESS OVERVIEW 135
11.2.5 NANOOMTECH CO., LTD. 136
TABLE 137 NANOOMTECH CO., LTD.: BUSINESS OVERVIEW 136
11.2.6 OSTEOSYS CORPORATION 137
TABLE 138 OSTEOSYS CORPORATION: BUSINESS OVERVIEW 137
11.2.7 FURUNO ELECTRIC CO., LTD. 138
TABLE 139 FURUNO ELECTRIC CO., LTD.: BUSINESS OVERVIEW 138
11.2.8 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD. 139
TABLE 140 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD.: BUSINESS OVERVIEW 139
11.2.9 XINGAOYI CO., LTD. 140
TABLE 141 XINGAOYI CO., LTD.: BUSINESS OVERVIEW 140
11.2.10 ANJUE MEDICAL EQUIPMENT CO., LTD. 141
TABLE 142 ANJUE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 141
11.2.11 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD. 142
TABLE 143 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 142
11.2.12 TRIVITRON HEALTHCARE 143
TABLE 144 TRIVITRON HEALTHCARE: BUSINESS OVERVIEW 143
11.2.13 OSCARE MEDICAL OY 144
TABLE 145 OSCARE MEDICAL OY: BUSINESS OVERVIEW 144
11.2.14 CYBERLOGIC, INC. 145
TABLE 146 CYBERLOGIC, INC.: BUSINESS OVERVIEW 145
11.2.15 NANJING KEJIN INDUSTRIAL CO., LTD. 146
TABLE 147 NANJING KEJIN INDUSTRIAL CO., LTD.: BUSINESS OVERVIEW 146
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 147
12.1 DISCUSSION GUIDE 147
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151
12.3 AVAILABLE CUSTOMIZATIONS 153
12.4 RELATED REPORTS 153
12.5 AUTHOR DETAILS 154



★調査レポート[世界の骨密度測定装置市場(~2027年):種類別(DEXA、末梢)、用途別(骨減少症&骨粗鬆症、嚢胞性線維症、CKD、体組成測定、関節リウマチ)、エンドユーザー別(病院&専門クリニック、診断センター)] (コード:MD7438-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の骨密度測定装置市場(~2027年):種類別(DEXA、末梢)、用途別(骨減少症&骨粗鬆症、嚢胞性線維症、CKD、体組成測定、関節リウマチ)、エンドユーザー別(病院&専門クリニック、診断センター)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆